IL140778A0 - Pharmaceutical compositions comprising component b and a human growth factor - Google Patents

Pharmaceutical compositions comprising component b and a human growth factor

Info

Publication number: IL140778A0
Authority: IL; Israel
Prior art keywords: growth factor; human growth; component; pharmaceutical compositions; compound
Prior art date: 1998-07-09

Application number

IL14077899A

Other languages

English (en)

Original Assignee

Applied Research Systems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-09

Filing date

1999-07-02

Publication date

2002-02-10

1999-07-02 Application filed by Applied Research Systems filed Critical Applied Research Systems

2002-02-10 Publication of IL140778A0 publication Critical patent/IL140778A0/xx

Links

239000003102 growth factor Substances 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
102100024785 Fibroblast growth factor 2 Human genes 0.000 abstract 1
108090000379 Fibroblast growth factor 2 Proteins 0.000 abstract 1
230000033115 angiogenesis Effects 0.000 abstract 1
230000001656 angiogenetic effect Effects 0.000 abstract 1
230000034303 cell budding Effects 0.000 abstract 1
230000002195 synergetic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Developmental Biology & Embryology (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

IL14077899A 1998-07-09 1999-07-02 Pharmaceutical compositions comprising component b and a human growth factor IL140778A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98112775		1998-07-09
PCT/EP1999/004605 WO2000002579A2 (en)	1998-07-09	1999-07-02	Component b as angiogenic agent in combination with human growth factors

Publications (1)

Publication Number	Publication Date
IL140778A0 true IL140778A0 (en)	2002-02-10

Family

ID=8232248

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14077899A IL140778A0 (en)	1998-07-09	1999-07-02	Pharmaceutical compositions comprising component b and a human growth factor
IL140778A IL140778A (en)	1998-07-09	2001-01-08	Pharmaceutical compositions comprising component b and a human growth factor

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL140778A IL140778A (en)	1998-07-09	2001-01-08	Pharmaceutical compositions comprising component b and a human growth factor

Country Status (12)

Country	Link
US (2)	US6855684B2 (da)
EP (1)	EP1093380B1 (da)
JP (1)	JP2002520292A (da)
AT (1)	ATE224200T1 (da)
AU (1)	AU765600B2 (da)
CA (1)	CA2336773C (da)
DE (1)	DE69903037T2 (da)
DK (1)	DK1093380T3 (da)
ES (1)	ES2184480T3 (da)
IL (2)	IL140778A0 (da)
PT (1)	PT1093380E (da)
WO (1)	WO2000002579A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1093380T3 (da) *	1998-07-09	2003-01-27	Applied Research Systems	Komponent B som angiogent middel i kombination med humane vækstfaktorer
WO2002022176A1 (en)	2000-09-15	2002-03-21	Genvec, Inc.	Method of modulating neovascularization
ES2359408T3 (es) *	2003-04-16	2011-05-23	Merck Serono Sa	Uso de slurp-1 para tratar enfermedades relacionadas con la disfunción de receptores de acetilcolina.
US20060128939A1 (en) *	2004-12-03	2006-06-15	Vijayendra Kumar	One pot process for making polymeric antioxidants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1257184B (it) *	1992-12-22	1996-01-10	Applied Research Systems	Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
ATE234110T1 (de) *	1996-04-24	2003-03-15	Applied Research Systems	Komponente b als wundheilendes mittel
DK1093380T3 (da) *	1998-07-09	2003-01-27	Applied Research Systems	Komponent B som angiogent middel i kombination med humane vækstfaktorer

1999
- 1999-07-02 DK DK99934563T patent/DK1093380T3/da active
- 1999-07-02 IL IL14077899A patent/IL140778A0/xx active IP Right Grant
- 1999-07-02 AT AT99934563T patent/ATE224200T1/de active
- 1999-07-02 PT PT99934563T patent/PT1093380E/pt unknown
- 1999-07-02 AU AU50306/99A patent/AU765600B2/en not_active Ceased
- 1999-07-02 EP EP99934563A patent/EP1093380B1/en not_active Expired - Lifetime
- 1999-07-02 ES ES99934563T patent/ES2184480T3/es not_active Expired - Lifetime
- 1999-07-02 DE DE69903037T patent/DE69903037T2/de not_active Expired - Lifetime
- 1999-07-02 CA CA002336773A patent/CA2336773C/en not_active Expired - Fee Related
- 1999-07-02 JP JP2000558838A patent/JP2002520292A/ja active Pending
- 1999-07-02 WO PCT/EP1999/004605 patent/WO2000002579A2/en not_active Ceased
2001
- 2001-01-08 IL IL140778A patent/IL140778A/en not_active IP Right Cessation
- 2001-01-09 US US09/756,185 patent/US6855684B2/en not_active Expired - Fee Related
2004
- 2004-12-10 US US11/008,175 patent/US7223732B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2336773A1 (en)	2000-01-20
US20050153892A1 (en)	2005-07-14
AU5030699A (en)	2000-02-01
WO2000002579A2 (en)	2000-01-20
JP2002520292A (ja)	2002-07-09
DE69903037T2 (de)	2003-06-05
WO2000002579A3 (en)	2000-02-24
EP1093380B1 (en)	2002-09-18
DE69903037D1 (de)	2002-10-24
PT1093380E (pt)	2003-01-31
US20010031733A1 (en)	2001-10-18
ATE224200T1 (de)	2002-10-15
AU765600B2 (en)	2003-09-25
US7223732B2 (en)	2007-05-29
CA2336773C (en)	2009-12-15
US6855684B2 (en)	2005-02-15
EP1093380A2 (en)	2001-04-25
ES2184480T3 (es)	2003-04-01
IL140778A (en)	2008-03-20
DK1093380T3 (da)	2003-01-27

Similar Documents

Publication	Publication Date	Title
IL133397A0 (en)	2001-04-30	Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
FI973828A0 (fi)	1997-09-29	Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
AP1450A (en)	2005-07-25	Solid oral dosage form comprising a combination of metformin and glibenclamide.
AU2002231544A1 (en)	2002-09-12	Therapeutic uses of herbal compositions
BG106030A (en)	2002-05-31	Pharmaceutical composition
ES2178036T3 (es)	2002-12-16	Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
MX9700885A (es)	1998-04-30	Nuevas heteroariloxazolidinonas.
NO865079L (no)	1987-06-18	Fremgangsmaate for fremstilling av stabiliserte humanvevplasminogenaktivatorpreparater.
NZ213113A (en)	1989-01-27	Substituted benzimidazoles, intermediates, and pharmaceutical compositions
GR3007385T3 (da)	1993-07-30
DK1167354T3 (da)	2003-09-01	Racemisk huperzin A
FI951789L (fi)	1995-04-13	Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
AU4830097A (en)	1998-06-18	Use of an extract of Cimicifuga
MX9204240A (es)	1993-01-01	Montaje distribuidor y de mezclado de dos etapas para preparaciones tal como cementos dentales.
IL146284A0 (en)	2002-07-25	Androgen glycosides and pharmaceutical compositions containing the same
AU5168493A (en)	1994-05-09	Ceramic reinforced dental appliances, devices and restorations
AU1815899A (en)	1999-06-28	Method and composition to enhance the efficacy of a vaccine using chemokines
ITRM910430A1 (it)	1992-12-17	Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
FI945439L (fi)	1994-11-18	Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät koostumukset
DE3675977D1 (de)	1991-01-17	Pharmazeutische zusammensetzungen zur verminderung der nebenwirkungen der anti-krebs-chemotherapie und erhoehung der immunitaet.
GT199900062A (es)	2000-10-20	Preparados efervescentes.
DK0613368T3 (da)	1998-01-26	Hudregenererende kosmetisk sammensætning
AP1691A (en)	2006-12-11	A pharmaceutical composition comprising therapeutically effective quantities of calcium channel blockers in combination with quinolines.
WO1999056697A3 (en)	2001-06-21	Pharmaceutical composition
DE69903037D1 (de)	2002-10-24	Komponente b als angiogenes mittel zusammen mit humanen wachstumsfaktoren

Legal Events

Date	Code	Title
2008-11-03	FF	Patent granted
2008-11-27	KB	Patent renewed
2010-02-14	KB	Patent renewed